Literature DB >> 8564642

Acquisition and use of human in vitro liver preparations.

A Guillouzo1.   

Abstract

Human in vitro liver preparations-i.e., slices, hepatocyte suspensions, primary hepatocyte cultures and microsomes-are increasingly used in the drug development process. The main applications are prediction of drug metabolite profiles, drug-drug interactions and toxicity. The use of these in vitro models is limited, however, because of their erratic availability, the absence of validated protocols and the difficulties of extrapolation of in vitro data to the in vivo situation.

Entities:  

Mesh:

Year:  1995        PMID: 8564642     DOI: 10.1007/bf00756515

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  11 in total

Review 1.  Report on the international workshop on the use of human in vitro liver preparations to study drug metabolism in drug development. Held at Utrecht, The Netherlands, 6-8 September 1994.

Authors:  P Skett; C Tyson; A Guillouzo; P Maier
Journal:  Biochem Pharmacol       Date:  1995-07-17       Impact factor: 5.858

2.  Viability and function in primary culture of adult hepatocytes from various animal species and human beings after cryopreservation.

Authors:  C Chesné; C Guyomard; A Fautrel; M G Poullain; B Frémond; H De Jong; A Guillouzo
Journal:  Hepatology       Date:  1993-08       Impact factor: 17.425

3.  Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type.

Authors:  C Guguen-Guillouzo; B Clément; G Baffet; C Beaumont; E Morel-Chany; D Glaise; A Guillouzo
Journal:  Exp Cell Res       Date:  1983-01       Impact factor: 3.905

4.  Isolated perfused cirrhotic human liver obtained from liver transplant patients: a feasibility study.

Authors:  J P Villeneuve; P M Huet; L Gariepy; D Fenyves; B Willems; J Côté; R Lapointe; D Marleau
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

5.  Expression of cytochrome P-450 enzymes in cultured human hepatocytes.

Authors:  F Morel; P H Beaune; D Ratanasavanh; J P Flinois; C S Yang; F P Guengerich; A Guillouzo
Journal:  Eur J Biochem       Date:  1990-07-31

6.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

Authors:  D Diaz; I Fabre; M Daujat; B Saint Aubert; P Bories; H Michel; P Maurel
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

7.  Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver.

Authors:  B Fremond; C Malandain; C Guyomard; C Chesne; A Guillouzo; J P Campion
Journal:  Cell Transplant       Date:  1993 Nov-Dec       Impact factor: 4.064

Review 8.  Use of human hepatocyte cultures for drug metabolism studies.

Authors:  A Guillouzo; F Morel; O Fardel; B Meunier
Journal:  Toxicology       Date:  1993-10-05       Impact factor: 4.221

9.  Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones.

Authors:  F Morel; O Fardel; D J Meyer; S Langouet; K S Gilmore; B Meunier; C P Tu; T W Kensler; B Ketterer; A Guillouzo
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

10.  Effect of xenobiotics on monooxygenase activities in cultured human hepatocytes.

Authors:  M T Donato; M J Gómez-Lechón; J V Castell
Journal:  Biochem Pharmacol       Date:  1990-04-15       Impact factor: 5.858

View more
  1 in total

1.  13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies for organ toxicity.

Authors:  H Spielmann; N P Bochkov; L Costa; L Gribaldo; A Guillouzo; J J Heindel; M Karol; R Parchment; W Pfaller; P P Peraita; T Zacharewski
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.